Softgel Capsules Market Global Insights And Revenue Growth Up To 2033
The softgel capsules market is expanding as pharmaceutical and nutraceutical manufacturers increasingly adopt convenient oral dosage forms for medicines, vitamins, dietary supplements, and specialty health products. Softgel capsules contain liquid or semi-solid formulations enclosed within a gelatin or non-animal-based shell. They are widely used for delivering ingredients such as omega-3 fatty acids, fat-soluble vitamins, herbal extracts, and active pharmaceutical ingredients that may require improved stability or absorption. Rising interest in preventive healthcare, growing consumption of dietary supplements, and advances in capsule manufacturing technologies are creating new opportunities. Manufacturers are also investing in plant-based materials, advanced encapsulation processes, and automated production to address changing consumer and industry requirements.
Track Market Growth and Metrics
The global softgel capsules market was valued at USD 8.5 billion in 2025 and is estimated to reach USD 9.1 billion in 2026. The market is projected to reach USD 15.4 billion by 2033, registering a CAGR of 7.9% from 2026 to 2033. Growth is supported by rising demand for dietary supplements, increasing pharmaceutical applications, and the adoption of softgel formulations for ingredients requiring improved bioavailability and formulation stability.
Key market metrics include:
- 2025 market size: USD 8.5 billion
- 2026 estimated market size: USD 9.1 billion
- 2033 projected market size: USD 15.4 billion
- Market CAGR:9% from 2026 to 2033
- Largest region: North America, with 41.2% revenue share in 2025
- Largest type segment: Gelatin-based or animal-based capsules, with 83.4% share in 2025
- Leading application: Vitamin and dietary supplements, with 23.2% share in 2025
- Largest end-use segment: Pharmaceutical companies, with 51.8% share in 2025
- Fastest-growing type: Non-animal-based capsules, with a projected CAGR of 13.3%
Pinpoint Key Market Drivers
The increasing consumption of vitamins, minerals, and dietary supplements is a major driver of market growth. Consumers are showing greater interest in preventive healthcare and nutritional products that support immunity, cardiovascular health, bone strength, and overall wellness. Softgel capsules are widely used for omega-3 fatty acids, vitamin D, vitamin E, coenzyme Q10, and botanical extracts because their shell can protect sensitive ingredients and provide convenient dosing.
Pharmaceutical manufacturers are also increasing the use of softgel formulations for active ingredients with low water solubility. Lipid-based formulations can help improve the delivery and absorption of certain compounds. Softgels also offer advantages such as dose uniformity, ease of swallowing, and protection from environmental exposure.
The expansion of contract development and manufacturing organizations (CDMOs) is creating additional opportunities. Pharmaceutical and nutraceutical companies increasingly outsource formulation development, encapsulation, and commercial production to specialized manufacturers. However, high equipment costs, stringent quality requirements, raw material price fluctuations, and complex manufacturing processes can create operational challenges.
Go Deeper! Ask Prism AI
about the Global Softgel Capsules Market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.
Analyze Segment Metrics
By type, gelatin-based or animal-based softgel capsules dominated the market, accounting for 83.4% of revenue in 2025. These capsules are widely used because of their established manufacturing processes, reliable sealing performance, mechanical strength, and compatibility with different liquid and semi-solid formulations. Their extensive use in pharmaceutical medicines and dietary supplements supports continued demand.
The non-animal-based segment is projected to grow at a CAGR of 13.3% through 2033. Increasing interest in vegetarian and vegan products is encouraging manufacturers to explore alternatives such as modified starch, pullulan, and other plant-based materials. Improvements in capsule shell performance are also supporting the development of non-animal formulations.
By application, vitamin and dietary supplements held the largest share at 23.2% in 2025. Demand is supported by growing consumption of nutritional supplements and convenient wellness products. The health supplement segment is projected to grow at a CAGR of 9.5%, supported by interest in functional nutrition, antioxidants, herbal ingredients, and preventive healthcare.
By end use, pharmaceutical companies accounted for the largest revenue share of 51.8% in 2025. Their demand is driven by the use of softgels in prescription medicines, over-the-counter products, and specialized formulations. Nutraceutical companies are expected to register strong growth, supported by expanding dietary supplement portfolios and consumer interest in daily wellness products.
Looking for more specific insights? Customize this report to suite your business needs
Identify Major Industry Players
The competitive landscape includes capsule manufacturers, pharmaceutical CDMOs, and specialized nutraceutical producers. Major industry participants include:
- Fuji Capsule
- Sirio Pharma Co., Ltd.
- CAPTEK Softgel International Inc.
- Thermo Fisher Scientific Inc.
- EyePoint Pharmaceuticals, Inc.
- Catalent, Inc.
- EuroCaps
- Aenova Group
- Lonza Capsules & Health Ingredients
- ProCaps Laboratories, LLC
- Soft Gel Technologies, Inc.
Companies are competing through manufacturing capacity, formulation expertise, quality assurance, and advanced encapsulation technologies. Investments in plant-based capsule materials, customized formulations, and contract manufacturing services are important strategies for strengthening market presence.
Spot Emerging 2026 Trends
Several developments are shaping the softgel capsules market in 2026. Plant-based softgel technology is gaining attention as consumers seek vegetarian and vegan alternatives. Manufacturers are developing non-animal capsule shells using modified starch, pullulan, and other materials to expand product choices across pharmaceutical and nutraceutical applications.
Another important trend is the growing use of advanced lipid-based drug delivery systems. These formulations can help address challenges associated with poorly water-soluble active ingredients. Research into modified-release and targeted oral delivery technologies is also expanding the potential applications of softgel capsules.
Automation and manufacturing efficiency are becoming increasingly important. Companies are investing in advanced encapsulation equipment, process monitoring, quality control, and production optimization to improve consistency and reduce manufacturing costs. CDMO outsourcing is also supporting demand for specialized production capabilities.
Sustainability is influencing material selection, capsule design, and manufacturing processes. Companies are exploring improved sourcing practices and production methods while maintaining product quality and regulatory compliance. In addition, e-commerce and digital distribution channels are expanding access to vitamins, dietary supplements, and other softgel-based health products.
Overall, the softgel capsules market is moving toward advanced drug delivery, plant-based alternatives, and more efficient manufacturing. Continued demand from pharmaceutical and nutraceutical companies is expected to support market growth through 2033.
U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database
About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.